Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
31.41
+0.73 (2.38%)
At close: Oct 23, 2026, 4:00 PM EDT
31.25
-0.16 (-0.51%)
After-hours: Oct 23, 2026, 4:41 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $2.21 billion as of October 23, 2026. It is the 6,259th most valuable company in the world and the 1,711th biggest in the United States. Its market cap has increased by 30.00% in one year.
Market Cap
2.21B
Enterprise Value
1.84B
1-Year Change
30.00%
Global Rank
Country Rank
#1,711 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $2.21B, an increase of 246.28%. That is a compound annual growth rate of 24.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 2.21B | 22.33% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.38B |
| SELLAS Life Sciences Group | 2.31B |
| MBX Biosciences | 2.31B |
| Celldex Therapeutics | 2.28B |
| Aurinia Pharmaceuticals | 2.25B |
| Fortrea Holdings | 2.24B |
| Agios Pharmaceuticals | 2.21B |
| Precigen | 2.21B |